Skip to search.
 FTSE 100 Down 0.04%

Gilead Sciences Inc. (GILD)

-NasdaqGS
72.36 Down 0.06(0.08%) 5 Dec 21:00
|Pre-Market : 72.75 Up 0.39 (0.54%) 09:57 - Nasdaq Real Time Price
Prev Close:72.42
Open:N/A
Bid:72.31 x 100
Ask:72.85 x 100
1y Target Est:95.74
Beta:0.887314
Earnings Date:31 Jan - 6 Feb (Est.)
Day's Range:N/A - N/A
52wk Range:71.39 - 104.79
Volume:0
Avg Vol (3m):9,622,780
Market Cap:95.33b
P/E (ttm):6.69
EPS (ttm):10.82
Div & Yield:1.88 (2.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.08%95.33b
GSKDown 0.08%89.76b
PFEDown 0.13%191.70b

Key Statistics

Forward P/E (1 yr):6.66
P/S (ttm):3.02
Ex-Dividend Date:13-Dec-16

Analysts

Annual EPS Est (Dec-16) :11.47
Quarterly EPS Est (Dec-16) :2.62
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-9.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback